Rahul File Dr

8/3/2019 Rahul File Dr

http://slidepdf.com/reader/full/rahul-file-dr 1/4

About Dr. Reddy's

Established in 1984, Dr. Reddy's Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to

providing affordable and innovative medicines for healthier lives. Through its four businesses - Pharmaceutical Services andActive Ingredients, Global Generics, Proprietary Products and Biosimilars ± Dr. Reddy¶s offers a portfolio of products andservices including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), Generics, Biosimilars,

Differentiated Formulations and News Chemical Entities (NCEs).

Pharmaceutical Services & Active Ingredients (PSAI)

Pharmaceutical Services and Active Ingredients, comprising our Active Pharmaceuticals and Custom Pharmaceuticalsbusinesses

Explore

Global Generics

Global Generics, which includes branded and unbranded generics

Explore

Proprietary Products

Proprietary Products, which includes New Chemical Entities (NCEs), Differentiated Formulations, and GenericBiopharmaceuticals.

Explore

Biosimilars

Biologics, or large molecule pharmaceuticals are complex, highly targeted and generally expensive therapies that are agrowing contributor to overall global healthcare spend.

Explore

Our Therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management, anti-infective and

paediatrics. Major markets include India, USA, Russia and CIS, Germany, UK, Venezuela, S. Africa, Romania, and New Zealand.



ICAI Gold Shield for Excellence in Financial Reporting in the Manufacturing sector (Sales more than 500 Crores) The award was presented by Dr. Veerappa Moily (Minister of Corporate Affairs) and Mr. K Rahman Khan (Deputy Chairman, Rajya Sabha) in a ICAIInternational Conference.

Thomson Reuters Innovation Award 2011 - India for PharmaCorporateat "Decade of Innovation: India @ Year 1" organized by the Confederation of Indian Industry and the National Innovation Council.

Pharmexcil Award (Gold Prize) for Export Excellencefor µOutstanding Export Performance for 2010-11¶ in the µLarge Scale Industry¶ category.

NHRD Inspire award 2011 for Learning & Development for organization best practices in the area of competency framework in the Non-IT sector

Dr. Anji Reddy conferred with Padma Bhushanthe third highest civilian award by the Government of India

Americares Spirit of Humanity Awardfor Best CSR by a Pharmaceutical Company



Executive of the Year Awardfor Dr. Anji Reddy by Bio Pharma Industry Asia Awards

Best CSR in the Pharmaceutical Sector at the India Shining Star CSR Awards 2011

Genome Valley Excellence Award 2011 for Dr. Anji Reddy for extraordinary and exemplary contributions to the Pharma Industry

Pharma Bio World 2011-Lifetime Achievement Award 2011 for Dr. Anji Reddy for futuristic approach towards manufacturing & producing affordable medicines

Best Employer in the Pharmaceutical industryand 13th Best in the country across all industries,by Outlook Business in association with Aon Hewitt

Infrastructure

Manufacturing Infrastructure and R&D Capabilities

Pharma Services & Active Ingredients



y Six FDA-approved plants in India

y One FDA-approved plant in Mexico

y

One FDA-approved plant in Mirfield, UKy Three Technology development centers

(Two in Hyderabad, India; One in Cambridge, UK)

Product Development

y Integrated Product development Capabilities that includes API development, Formulations development and analytical

development skills.

y One Integrated Product development facility in Hyderbad, India.

Global Generics

y Seven Formulation plants in India (Two USFDA inspected)

y Two USFDA inspected plant in USA

New Chemical Entities

y Research in the areas of metabolic, cardiovascular, anti-bacterials, and pain & inflammation.

Biologics

y Biologics development center

y GMP production

y E coli and mammalian cell platforms

Documents

Rahul File Dr